Literature DB >> 19361523

Structural alterations within native amyloidogenic immunoglobulin light chains.

Edward G Randles1, James R Thompson, Douglas J Martin, Marina Ramirez-Alvarado.   

Abstract

Amyloid diseases are characterized by the misfolding of a precursor protein that leads to amyloid fibril formation. Despite the fact that there are different precursors, some commonalities in the misfolding mechanism are thought to exist. In light chain amyloidosis (AL), the immunoglobulin light chain forms amyloid fibrils that deposit in the extracellular space of vital organs. AL proteins are thermodynamically destabilized compared to non-amyloidogenic proteins and some studies have linked this instability to increased fibril formation rates. Here we present the crystal structures of two highly homologous AL proteins, AL-12 and AL-103. This structural study shows that these proteins retain the canonical germ line dimer interface. We highlight important structural alterations in two loops flanking the dimer interface and correlate these results with the somatic mutations present in AL-12 and AL-103. We suggest that these alterations are informative structural features that are likely contributing to protein instability that leads to conformational changes involved in the initial events of amyloid formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361523      PMCID: PMC2840394          DOI: 10.1016/j.jmb.2009.04.010

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  35 in total

1.  Structural relationship of kappa-type light chains with AL amyloidosis: multiple deletions found in a VkappaIV protein.

Authors:  M A Alim; S Yamaki; M S Hossain; K Takeda; M Kozima; T Izumi; I Takashi; T Shinoda
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model.

Authors:  A A Vaguine; J Richelle; S J Wodak
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-01-01

3.  The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution.

Authors:  O Epp; E E Lattman; M Schiffer; R Huber; W Palm
Journal:  Biochemistry       Date:  1975-11-04       Impact factor: 3.162

4.  Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.

Authors:  Jonathan S Wall; Vibha Gupta; Matthew Wilkerson; Maria Schell; Remy Loris; Paul Adams; Alan Solomon; Fred Stevens; Chris Dealwis
Journal:  J Mol Recognit       Date:  2004 Jul-Aug       Impact factor: 2.137

5.  The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.

Authors:  Richard W McLaughlin; Janelle K De Stigter; Laura A Sikkink; Elizabeth M Baden; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

Review 6.  The folding of an enzyme. II. Substructure of barnase and the contribution of different interactions to protein stability.

Authors:  L Serrano; J T Kellis; P Cann; A Matouschek; A R Fersht
Journal:  J Mol Biol       Date:  1992-04-05       Impact factor: 5.469

7.  Mechanisms of protein fibril formation: nucleated polymerization with competing off-pathway aggregation.

Authors:  Evan T Powers; David L Powers
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

8.  Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain.

Authors:  K E Olsen; K Sletten; P Westermark
Journal:  Biochem Biophys Res Commun       Date:  1998-04-28       Impact factor: 3.575

9.  Tertiary structure of human lambda 6 light chains.

Authors:  P R Pokkuluri; A Solomon; D T Weiss; F J Stevens; M Schiffer
Journal:  Amyloid       Date:  1999-09       Impact factor: 7.141

10.  Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity.

Authors:  J Wall; M Schell; C Murphy; R Hrncic; F J Stevens; A Solomon
Journal:  Biochemistry       Date:  1999-10-19       Impact factor: 3.162

View more
  17 in total

1.  Comparison of amyloid fibril formation by two closely related immunoglobulin light chain variable domains.

Authors:  Douglas J Martin; Marina Ramirez-Alvarado
Journal:  Amyloid       Date:  2010-09       Impact factor: 7.141

2.  Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.

Authors:  Marta Marin-Argany; Jofre Güell-Bosch; Luis M Blancas-Mejía; Sandra Villegas; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2015-09-07       Impact factor: 6.725

3.  Site-directed mutagenesis reveals regions implicated in the stability and fiber formation of human λ3r light chains.

Authors:  Miryam I Villalba; Juan C Canul-Tec; Oscar D Luna-Martínez; Rosalba Sánchez-Alcalá; Timoteo Olamendi-Portugal; Enrique Rudiño-Piñera; Sonia Rojas; Rosana Sánchez-López; Daniel A Fernández-Velasco; Baltazar Becerril
Journal:  J Biol Chem       Date:  2014-12-11       Impact factor: 5.157

4.  Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.

Authors:  Luis M Blancas-Mejía; Pinaki Misra; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2017-01-24       Impact factor: 3.162

5.  Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.

Authors:  Ara Celi DiCostanzo; James R Thompson; Francis C Peterson; Brian F Volkman; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

6.  Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2016-05-16       Impact factor: 3.162

7.  Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction.

Authors:  Douglas J Martin; Marina Ramirez-Alvarado
Journal:  Biophys Chem       Date:  2011-05-18       Impact factor: 2.352

8.  Mechanistic Insights into the Early Events in the Aggregation of Immunoglobulin Light Chains.

Authors:  Pinaki Misra; Luis M Blancas-Mejia; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2019-07-09       Impact factor: 3.162

9.  Utility of Doppler myocardial imaging, cardiac biomarkers, and clonal immunoglobulin genes to assess left ventricular performance and stratify risk following peripheral blood stem cell transplantation in patients with systemic light chain amyloidosis (Al).

Authors:  Diego Bellavia; Roshini S Abraham; Patricia A Pellikka; Angela Dispenzieri; John C Burnett; Ghormallah B Al-Zahrani; Tammy D Green; Michelle K Manske; Morie A Gertz; Fletcher A Miller; Theodore P Abraham
Journal:  J Am Soc Echocardiogr       Date:  2011-02-18       Impact factor: 5.251

10.  Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations.

Authors:  Luis M Blancas-Mejía; Alexander Tischer; James R Thompson; Jonathan Tai; Lin Wang; Matthew Auton; Marina Ramirez-Alvarado
Journal:  J Mol Biol       Date:  2013-10-22       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.